Bio-IT World December 19, 2023
Researchers at the CNIO (Spanish National Cancer Research Centre) are forwarding the idea that metastasis, rather than the primary tumor, should be the focus of cancer treatment, which would both further the cause of personalized medicine and generate biomarkers of sensitivity or resistance to specific drugs. The means is the world’s first repository of brain metastasis living samples, co-created by Manuel Valiente, head of the Brain Metastasis Group at CNIO, and Eva Ortega-Paíno, director of the CNIO Biobank.
To date, 200 fresh samples have been donated from brain metastasis patients undergoing surgery at 18 hospitals in RENACER (National Brain Metastasis Network), which the pair established in 2021 to accelerate the search for antimetastatic therapies. They have...
Today's Sponsors
Today's Sponsor